MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 152 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,024,114 | +53.8% | 13,860 | +143.3% | 0.00% | 0.0% |
| Q2 2023 | $1,315,776 | +2.7% | 5,696 | +7.7% | 0.00% | 0.0% |
| Q1 2023 | $1,281,555 | -11.4% | 5,290 | +6.1% | 0.00% | 0.0% |
| Q4 2022 | $1,447,187 | +337.3% | 4,986 | -2.1% | 0.00% | – |
| Q3 2022 | $330,929 | -11.0% | 5,092 | -2.0% | 0.00% | – |
| Q2 2022 | $371,787 | -23.9% | 5,194 | +4.3% | 0.00% | – |
| Q1 2022 | $488,638 | -6.7% | 4,980 | -19.5% | 0.00% | – |
| Q4 2021 | $524,000 | +7.2% | 6,183 | +0.9% | 0.00% | – |
| Q3 2021 | $489,000 | -23.8% | 6,127 | -7.0% | 0.00% | -100.0% |
| Q2 2021 | $642,000 | +6.8% | 6,587 | +28.2% | 0.00% | 0.0% |
| Q1 2021 | $601,000 | 0.0% | 5,137 | -5.0% | 0.00% | 0.0% |
| Q4 2020 | $601,000 | -4.0% | 5,407 | +2.5% | 0.00% | 0.0% |
| Q3 2020 | $626,000 | +13.4% | 5,276 | -1.7% | 0.00% | 0.0% |
| Q2 2020 | $552,000 | +47.2% | 5,369 | -4.4% | 0.00% | – |
| Q1 2020 | $375,000 | -16.1% | 5,619 | +14.5% | 0.00% | – |
| Q4 2019 | $447,000 | +3.0% | 4,907 | -3.7% | 0.00% | – |
| Q3 2019 | $434,000 | -18.7% | 5,098 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $534,000 | -9.2% | 5,098 | +8.6% | 0.00% | 0.0% |
| Q1 2019 | $588,000 | +23.3% | 4,695 | +10.9% | 0.00% | 0.0% |
| Q4 2018 | $477,000 | -52.1% | 4,235 | -8.9% | 0.00% | 0.0% |
| Q3 2018 | $996,000 | -21.1% | 4,651 | +3.0% | 0.00% | 0.0% |
| Q2 2018 | $1,263,000 | +187.7% | 4,516 | +19.9% | 0.00% | – |
| Q1 2018 | $439,000 | +34.7% | 3,765 | +6.0% | 0.00% | – |
| Q4 2017 | $326,000 | +239.6% | 3,553 | +64.9% | 0.00% | – |
| Q3 2017 | $96,000 | +9500.0% | 2,154 | +3319.0% | 0.00% | – |
| Q2 2017 | $1,000 | – | 63 | +117.2% | 0.00% | – |
| Q1 2017 | $0 | – | 29 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | – | 29 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | – | 29 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
| University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
| Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
| TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
| Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
| Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
| Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
| Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
| MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
| Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |